{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T04:48:39Z","timestamp":1794890919662,"version":"4.9.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,2,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Perineural invasion (PNI) frequently occurs in oral squamous cell carcinoma (OSCC) and predicts poor prognosis. Although PNI is increasingly recognised as a process driven by tumour-nerve crosstalk, the underlying molecular mechanisms remain unclear. We investigated the role of sympathetic nerve\u2013derived neuropeptide Y (NPY) and its receptor NPY1R in OSCC PNI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>NPY\/NPY1R expression was assessed in human OSCC tissues by immunostaining, qPCR, and TCGA data analysis. Functional studies using Cal27 and SCC9 cells included migration, invasion, and sphere assays. The causal role of NPY1R was tested by lentiviral knockdown\/overexpression, validated in tongue orthotopic xenografts, and further examined by NPY1R pharmacological inhibition in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NPY was enriched in the PNI microenvironment, and malignant OSCC expressed high NPY1R, particularly at invasive fronts. Mechanistically, NPY activated ERK and Smad2 via NPY1R, synergising with TGF\u03b2 signalling in tumour cells expressing T\u03b2RI. This crosstalk enhanced proliferation, invasion, and PNI in vivo. Importantly, NPY1R inhibition markedly reduced tumour growth, metastasis, and PNI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We identify NPY-NPY1R-TGF\u03b2 crosstalk as a novel mechanism enabling OSCC to exploit neural signals for PNI, highlighting a promising therapeutic target to block neural invasion and improve patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-025-03261-5","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:12:32Z","timestamp":1764169952000},"page":"377-390","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Crosstalk of NPY and TGF\u03b2 orchestrates the signaling to facilitate perineural invasion of oral squamous cell carcinoma"],"prefix":"10.1038","volume":"134","author":[{"given":"Jing","family":"Bi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junting","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6737-7230","authenticated-orcid":false,"given":"Marene","family":"Landstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3193-1425","authenticated-orcid":false,"given":"Yabing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3081-4780","authenticated-orcid":false,"given":"Guangxiang","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"3261_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.5858\/2005-129-354-PAVIIO","volume":"129","author":"KA Kurtz","year":"2005","unstructured":"Kurtz KA, Hoffman HT, Zimmerman MB, Robinson RA. Perineural and vascular invasion in oral cavity squamous carcinoma: increased incidence on re-review of slides and by using immunohistochemical enhancement. Arch Pathol Lab Med. 2005;129:354\u20139.","journal-title":"Arch Pathol Lab Med"},{"key":"3261_CR2","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1177\/0022034518756297","volume":"97","author":"LB Schmitd","year":"2018","unstructured":"Schmitd LB, Scanlon CS, D\u2019Silva NJ. Perineural invasion in head and neck cancer. J Dent Res. 2018;97:742\u201350.","journal-title":"J Dent Res"},{"key":"3261_CR3","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/hed.25170","volume":"40","author":"D Nair","year":"2018","unstructured":"Nair D, Mair M, Singhvi H, Mishra A, Nair S, Agrawal J, et al. Perineural invasion: independent prognostic factor in oral cancer that warrants adjuvant treatment. Head Neck. 2018;40:1780\u20137.","journal-title":"Head Neck"},{"key":"3261_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7885","volume":"6","author":"CS Scanlon","year":"2015","unstructured":"Scanlon CS, Banerjee R, Inglehart RC, Liu M, Russo N, Hariharan A, et al. Galanin modulates the neural niche to favour perineural invasion in head and neck cancer. Nat Commun. 2015;6:6885.","journal-title":"Nat Commun"},{"key":"3261_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41568-019-0237-2","volume":"20","author":"AH Zahalka","year":"2020","unstructured":"Zahalka AH, Frenette PS. Nerves in cancer. Nat Rev Cancer. 2020;20:143\u201357.","journal-title":"Nat Rev Cancer"},{"key":"3261_CR6","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13046-018-0674-x","volume":"37","author":"N Kuol","year":"2018","unstructured":"Kuol N, Stojanovska L, Apostolopoulos V, Nurgali K. Role of the nervous system in cancer metastasis. J Exp Clin Cancer Res. 2018;37:5.","journal-title":"J Exp Clin Cancer Res"},{"issue":"Suppl 2","key":"3261_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/head.13084","volume":"57","author":"AF Russo","year":"2017","unstructured":"Russo AF. Overview of neuropeptides: awakening the senses?. Headache. 2017;57(Suppl 2):37\u201346.","journal-title":"Headache"},{"key":"3261_CR8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.neuron.2012.09.014","volume":"76","author":"AN van den Pol","year":"2012","unstructured":"van den Pol AN. Neuropeptide transmission in brain circuits. Neuron. 2012;76:98\u2013115.","journal-title":"Neuron"},{"key":"3261_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejphar.2003.08.089","volume":"480","author":"H Herzog","year":"2003","unstructured":"Herzog H. Neuropeptide Y and energy homeostasis: insights from Y receptor knockout models. Eur J Pharm. 2003;480:21\u20139.","journal-title":"Eur J Pharm"},{"key":"3261_CR10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.molmet.2017.03.013","volume":"6","author":"K Loh","year":"2017","unstructured":"Loh K, Zhang L, Brandon A, Wang Q, Begg D, Qi Y, et al. Insulin controls food intake and energy balance via NPY neurons. Mol Metab. 2017;6:574\u201384.","journal-title":"Mol Metab"},{"key":"3261_CR11","doi-asserted-by":"publisher","first-page":"695623","DOI":"10.3389\/fcell.2021.695623","volume":"9","author":"Y Huang","year":"2021","unstructured":"Huang Y, Lin X, Lin S. Neuropeptide Y and metabolism syndrome: an update on perspectives of clinical therapeutic intervention strategies. Front Cell Dev Biol. 2021;9:695623.","journal-title":"Front Cell Dev Biol"},{"key":"3261_CR12","doi-asserted-by":"crossref","unstructured":"Sanchez ML, Rodriguez FD, Covenas R. Neuropeptide Y peptide family and cancer: antitumor therapeutic strategies. Int J Mol Sci. 2023;24:9962.","DOI":"10.3390\/ijms24129962"},{"key":"3261_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.peptides.2006.08.037","volume":"28","author":"M Korner","year":"2007","unstructured":"Korner M, Reubi JC. NPY receptors in human cancer: a review of current knowledge. Peptides. 2007;28:419\u201325.","journal-title":"Peptides"},{"key":"3261_CR14","doi-asserted-by":"publisher","first-page":"3557","DOI":"10.1158\/1078-0432.CCR-21-4543","volume":"28","author":"LB Schmitd","year":"2022","unstructured":"Schmitd LB, Perez-Pacheco C, Bellile EL, Wu W, Casper K, Mierzwa M, et al. Spatial and transcriptomic analysis of perineural invasion in oral cancer. Clin Cancer Res. 2022;28:3557\u201372.","journal-title":"Clin Cancer Res"},{"key":"3261_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1186\/s13046-022-02561-5","volume":"41","author":"B Wang","year":"2022","unstructured":"Wang B, Gan J, Liu Z, Hui Z, Wei J, Gu X, et al. An organoid library of salivary gland tumors reveals subtype-specific characteristics and biomarkers. J Exp Clin Cancer Res. 2022;41:350.","journal-title":"J Exp Clin Cancer Res"},{"key":"3261_CR16","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/ijc.34856","volume":"154","author":"Z Hui","year":"2024","unstructured":"Hui Z, Wang B, Liu Z, Wei J, Gan J, Landstrom M, et al. TGFbeta-induced EN1 promotes tumor budding of adenoid cystic carcinoma in patient-derived organoid model. Int J Cancer. 2024;154:1814\u201327.","journal-title":"Int J Cancer"},{"key":"3261_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41368-022-00162-8","volume":"14","author":"N Swarup","year":"2022","unstructured":"Swarup N, Hong KO, Chawla K, Choi SJ, Shin JA, Oh KY, et al. Effect of PAIP1 on the metastatic potential and prognostic significance in oral squamous cell carcinoma. Int J Oral Sci. 2022;14:9.","journal-title":"Int J Oral Sci"},{"key":"3261_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"N Cancer Genome Atlas","year":"2015","unstructured":"Cancer Genome Atlas N. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517:576\u201382.","journal-title":"Nature"},{"key":"3261_CR19","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1038\/s41388-019-0722-9","volume":"38","author":"G Zang","year":"2019","unstructured":"Zang G, Mu Y, Gao L, Bergh A, Landstrom M. PKCzeta facilitates lymphatic metastatic spread of prostate cancer cells in a mice xenograft model. Oncogene. 2019;38:4215\u201331.","journal-title":"Oncogene"},{"key":"3261_CR20","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/000348948509400420","volume":"94","author":"JG Batsakis","year":"1985","unstructured":"Batsakis JG. Nerves and neurotropic carcinomas. Ann Otol Rhinol Laryngol. 1985;94:426\u20137.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"3261_CR21","doi-asserted-by":"publisher","first-page":"3379","DOI":"10.1002\/cncr.24396","volume":"115","author":"C Liebig","year":"2009","unstructured":"Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115:3379\u201391.","journal-title":"Cancer"},{"key":"3261_CR22","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1158\/1078-0432.CCR-22-3496","volume":"29","author":"C Perez-Pacheco","year":"2023","unstructured":"Perez-Pacheco C, Schmitd LB, Furgal A, Bellile EL, Liu M, Fattah A, et al. Increased nerve density adversely affects outcome in oral cancer. Clin Cancer Res. 2023;29:2501\u201312.","journal-title":"Clin Cancer Res"},{"key":"3261_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41571-020-0422-y","volume":"18","author":"A Lugli","year":"2021","unstructured":"Lugli A, Zlobec I, Berger MD, Kirsch R, Nagtegaal ID. Tumour budding in solid cancers. Nat Rev Clin Oncol. 2021;18:101\u201315.","journal-title":"Nat Rev Clin Oncol"},{"key":"3261_CR24","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1582-4934.2009.00956.x","volume":"15","author":"MY Son","year":"2011","unstructured":"Son MY, Kim MJ, Yu K, Koo DB, Cho YS. Involvement of neuropeptide Y and its Y1 and Y5 receptors in maintaining self-renewal and proliferation of human embryonic stem cells. J Cell Mol Med. 2011;15:152\u201365.","journal-title":"J Cell Mol Med"},{"key":"3261_CR25","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00441-011-1201-y","volume":"347","author":"Y Mu","year":"2012","unstructured":"Mu Y, Gudey SK, Landstrom M. Non-smad signaling pathways. Cell Tissue Res. 2012;347:11\u201320.","journal-title":"Cell Tissue Res"},{"key":"3261_CR26","doi-asserted-by":"crossref","unstructured":"Tzavlaki K, Moustakas A. TGF-beta signaling. Biomolecules. 2020;10:487\u2013525.","DOI":"10.3390\/biom10030487"},{"key":"3261_CR27","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/35073601","volume":"410","author":"DE Hansel","year":"2001","unstructured":"Hansel DE, Eipper BA, Ronnett GV. Neuropeptide Y functions as a neuroproliferative factor. Nature. 2001;410:940\u20134.","journal-title":"Nature"},{"key":"3261_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00210-002-0588-0","volume":"366","author":"R Seifert","year":"2002","unstructured":"Seifert R, Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharm. 2002;366:381\u2013416.","journal-title":"Naunyn Schmiedebergs Arch Pharm"},{"key":"3261_CR29","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/35082096","volume":"411","author":"F Ango","year":"2001","unstructured":"Ango F, Prezeau L, Muller T, Tu JC, Xiao B, Worley PF, et al. Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature. 2001;411:962\u20135.","journal-title":"Nature"},{"key":"3261_CR30","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1111\/bph.12877","volume":"171","author":"MS Engelstoft","year":"2014","unstructured":"Engelstoft MS, Norn C, Hauge M, Holliday ND, Elster L, Lehmann J, et al. Structural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119. Br J Pharm. 2014;171:5774\u201389.","journal-title":"Br J Pharm"},{"key":"3261_CR31","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/s41416-023-02240-y","volume":"128","author":"F Stogbauer","year":"2023","unstructured":"Stogbauer F, Beck S, Ourailidis I, Hess J, Poremba C, Lauterbach M, et al. Tumour budding-based grading as independent prognostic biomarker in HPV-positive and HPV-negative head and neck cancer. Br J Cancer. 2023;128:2295\u2013306.","journal-title":"Br J Cancer"},{"key":"3261_CR32","doi-asserted-by":"publisher","first-page":"e2200188","DOI":"10.1002\/adbi.202200188","volume":"7","author":"NJ D\u2019Silva","year":"2023","unstructured":"D\u2019Silva NJ, Perez-Pacheco C, Schmitd LB. The 3D\u2019s of neural phenotypes in oral cancer: distance, diameter, and density. Adv Biol. 2023;7:e2200188.","journal-title":"Adv Biol"},{"key":"3261_CR33","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1158\/0008-5472.CAN-20-2793","volume":"81","author":"DA Silverman","year":"2021","unstructured":"Silverman DA, Martinez VK, Dougherty PM, Myers JN, Calin GA, Amit M. Cancer-associated neurogenesis and nerve-cancer cross-talk. Cancer Res. 2021;81:1431\u201340.","journal-title":"Cancer Res"},{"key":"3261_CR34","first-page":"1","volume":"9","author":"SH Chen","year":"2019","unstructured":"Chen SH, Zhang BY, Zhou B, Zhu CZ, Sun LQ, Feng YJ. Perineural invasion of cancer: a complex crosstalk between cells and molecules in the perineural niche. Am J Cancer Res. 2019;9:1\u201321.","journal-title":"Am J Cancer Res"},{"key":"3261_CR35","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2337\/db06-0567","volume":"56","author":"X Fioramonti","year":"2007","unstructured":"Fioramonti X, Contie S, Song Z, Routh VH, Lorsignol A, Penicaud L. Characterization of glucosensing neuron subpopulations in the arcuate nucleus: integration in neuropeptide Y and pro-opio melanocortin networks?. Diabetes. 2007;56:1219\u201327.","journal-title":"Diabetes"},{"key":"3261_CR36","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/mp.2014.30","volume":"19","author":"M Koch","year":"2014","unstructured":"Koch M, Horvath TL. Molecular and cellular regulation of hypothalamic melanocortin neurons controlling food intake and energy metabolism. Mol Psychiatry. 2014;19:752\u201361.","journal-title":"Mol Psychiatry"},{"key":"3261_CR37","doi-asserted-by":"publisher","first-page":"e12898","DOI":"10.1111\/jne.12898","volume":"32","author":"L Zhang","year":"2020","unstructured":"Zhang L, Reed F, Herzog H. Leptin signalling on arcuate NPY neurones controls adiposity independent of energy balance or diet composition. J Neuroendocrinol. 2020;32:e12898.","journal-title":"J Neuroendocrinol"},{"key":"3261_CR38","doi-asserted-by":"publisher","unstructured":"Merten N, Beck-Sickinger AG. Molecular ligand-receptor interaction of the NPY\/PP peptide family. EXS https:\/\/doi.org\/10.1007\/3-7643-7417-9_3, 2006:35\u201362.","DOI":"10.1007\/3-7643-7417-9_3"},{"key":"3261_CR39","doi-asserted-by":"publisher","first-page":"580378","DOI":"10.3389\/fimmu.2020.580378","volume":"11","author":"WC Chen","year":"2020","unstructured":"Chen WC, Liu YB, Liu WF, Zhou YY, He HF, Lin S. Neuropeptide Y is an immunomodulatory factor: direct and indirect. Front Immunol. 2020;11:580378.","journal-title":"Front Immunol"},{"key":"3261_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10555-024-10237-z","volume":"44","author":"D Sigorski","year":"2025","unstructured":"Sigorski D, Sejda A, Abualsaud N, Krawczyk E, Izycka-Swieszewska E, Kitlinska J. Neuropeptide Y in cancer-biological functions and potential clinical implications. Cancer Metastasis Rev. 2025;44:21.","journal-title":"Cancer Metastasis Rev"},{"key":"3261_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-5728(02)00424-1","volume":"134","author":"S Bedoui","year":"2003","unstructured":"Bedoui S, Kawamura N, Straub RH, Pabst R, Yamamura T, von Horsten S. Relevance of neuropeptide Y for the neuroimmune crosstalk. J Neuroimmunol. 2003;134:1\u201311.","journal-title":"J Neuroimmunol"},{"key":"3261_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.cellsig.2018.09.002","volume":"52","author":"A Vander Ark","year":"2018","unstructured":"Vander Ark A, Cao J, Li X. TGF-beta receptors: in and beyond TGF-beta signaling. Cell Signal. 2018;52:112\u201320.","journal-title":"Cell Signal"},{"key":"3261_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03609-x","volume":"9","author":"S Wojciech","year":"2018","unstructured":"Wojciech S, Ahmad R, Belaid-Choucair Z, Journe AS, Gallet S, Dam J, et al. The orphan GPR50 receptor promotes constitutive TGFbeta receptor signaling and protects against cancer development. Nat Commun. 2018;9:1216.","journal-title":"Nat Commun"},{"key":"3261_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-10993-1","volume":"23","author":"SA Pascetta","year":"2023","unstructured":"Pascetta SA, Kirsh SM, Cameron M, Uniacke J. Pharmacological inhibition of neuropeptide Y receptors Y1 and Y5 reduces hypoxic breast cancer migration, proliferation, and signaling. BMC Cancer. 2023;23:494.","journal-title":"BMC Cancer"},{"key":"3261_CR45","doi-asserted-by":"publisher","first-page":"5803","DOI":"10.1007\/s00432-022-04540-x","volume":"149","author":"D Sigorski","year":"2023","unstructured":"Sigorski D, Wesolowski W, Gruszecka A, Gulczynski J, Zielinski P, Misiukiewicz S, et al. Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread. J Cancer Res Clin Oncol. 2023;149:5803\u201322.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3261_CR46","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1038\/onc.2014.253","volume":"34","author":"M Czarnecka","year":"2015","unstructured":"Czarnecka M, Trinh E, Lu C, Kuan-Celarier A, Galli S, Hong SH, et al. Neuropeptide Y receptor Y5 as an inducible pro-survival factor in neuroblastoma: implications for tumor chemoresistance. Oncogene. 2015;34:3131\u201343.","journal-title":"Oncogene"},{"key":"3261_CR47","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1038\/onc.2010.301","volume":"29","author":"C Lu","year":"2010","unstructured":"Lu C, Everhart L, Tilan J, Kuo L, Sun CC, Munivenkatappa RB, et al. Neuropeptide Y and its Y2 receptor: potential targets in neuroblastoma therapy. Oncogene. 2010;29:5630\u201342.","journal-title":"Oncogene"},{"key":"3261_CR48","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1172\/JCI131919","volume":"130","author":"P Dietrich","year":"2020","unstructured":"Dietrich P, Wormser L, Fritz V, Seitz T, De Maria M, Schambony A, et al. Molecular crosstalk between Y5 receptor and neuropeptide Y drives liver cancer. J Clin Investig. 2020;130:2509\u201326.","journal-title":"J Clin Investig"},{"key":"3261_CR49","doi-asserted-by":"publisher","first-page":"27494","DOI":"10.1074\/jbc.M111.224089","volume":"286","author":"C Lu","year":"2011","unstructured":"Lu C, Tilan JU, Everhart L, Czarnecka M, Soldin SJ, Mendu DR, et al. Dipeptidyl peptidases as survival factors in Ewing sarcoma family of tumors: implications for tumor biology and therapy. J Biol Chem. 2011;286:27494\u2013505.","journal-title":"J Biol Chem"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03261-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03261-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03261-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T17:02:06Z","timestamp":1769619726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03261-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2,8]]}},"alternative-id":["3261"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03261-5","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"22 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The human specimens involved in this study were reviewed and approved by the Ethics Committee of Stomatology Hospital, China Medical University. All the experiments were undertaken following Ethical permission (No. G2020004), and the study methodologies conformed to the standards set by the Declaration of Helsinki. All animal experiments were performed following the procedures granted by the China Medical University animal care committee (CMU2023684). All experiments were performed in accordance with the approved protocol and other relevant guidelines and regulations. Animal welfare was protected following the protocol granted by the animal care committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}